Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US
Anne M. Hause, Bicheng Zhang, Xin Yue, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2222241-e2222241
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 68
Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies
C. Janssen, Anne Mosnier, G. Gavazzi, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 40
Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021–June 30, 2022
Pedro L. Moro, Bicheng Zhang, Carol Ennulat, et al.
Vaccine (2023) Vol. 41, Iss. 11, pp. 1859-1863
Open Access | Times Cited: 20
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic
Lauri E. Markowitz, Robert Hopkins, Karen R. Broder, et al.
Vaccine (2024) Vol. 42, pp. 125549-125549
Open Access | Times Cited: 7
Adult Vaccine Coadministration Is Safe, Effective, and Acceptable: Results of a Survey of the Literature
Litjen Tan, Dana Trevas, Ann R. Falsey
Influenza and Other Respiratory Viruses (2025) Vol. 19, Iss. 3
Open Access
Recommendations for Prevention and Control of Influenza in Children, 2023–2024
Sean T. O’Leary, James D. Campbell, Monica I. Ardura, et al.
PEDIATRICS (2023) Vol. 152, Iss. 4
Closed Access | Times Cited: 15
Overview of COVID-19 Infection, Treatment, and Prevention in Children
Carol Kao
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 424-424
Open Access | Times Cited: 4
Safety of Simultaneous Administration of Bivalent mRNA COVID-19 and Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS)
Pedro L. Moro, Carol Ennulat, Hannah Brown, et al.
Drug Safety (2024) Vol. 47, Iss. 5, pp. 487-493
Closed Access | Times Cited: 4
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
Louise Murdoch, Karen Quan, James A. Baber, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 9, pp. 2241-2258
Open Access | Times Cited: 10
Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine
Leah J. McGrath, Deepa Malhotra, Amanda C. Miles, et al.
JAMA Network Open (2023) Vol. 6, Iss. 11, pp. e2342151-e2342151
Open Access | Times Cited: 10
Concurrent Administration of COVID-19 and Influenza Vaccines Enhances Spike-Specific Antibody Responses
Susanna E Barouch, Taras M. Chicz, Ross Blanc, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 4
Open Access | Times Cited: 3
Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity
Zhigang Xie, Hanadi Hamadi, Arch G. Mainous, et al.
Vaccine (2022) Vol. 41, Iss. 4, pp. 875-878
Open Access | Times Cited: 13
Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 months and Older in the United States
Patricia C. Lloyd, Elizabeth R. Smith, Joann F. Gruber, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Assessing the determinants of influenza and COVID-19 vaccine co-administration decisions in the elderly
Seunghyun Lewis Kwon, So-Yeon Kim, Minju Song, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines
Emmanuel B. Walter, Elizabeth P. Schlaudecker, Kawsar R. Talaat, et al.
JAMA Network Open (2024) Vol. 7, Iss. 11, pp. e2443166-e2443166
Open Access | Times Cited: 2
Co-administration of COVID-19 and influenza vaccines
Arnaud M. Didierlaurent, Paul‐Henri Lambert
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 5, pp. 558-559
Open Access | Times Cited: 5
Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines
Tat’Yana A. Kenigsberg, Kristin Goddard, Kayla E. Hanson, et al.
Vaccine (2023) Vol. 41, Iss. 39, pp. 5678-5682
Open Access | Times Cited: 5
Co-administration of SARS-CoV-2 and influenza vaccines in healthcare workers: Results of two vaccination campaigns in a large teaching hospital in Rome
Domenico Pascucci, Alberto Lontano, Luca Regazzi, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 5
Reactogenicity and Concomitant Administration of the COVID-19 Booster and Influenza Vaccine
Kathryn T. Hall, Valerie E. Stone, Bisola O. Ojikutu
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2222246-e2222246
Open Access | Times Cited: 8
Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020—May 19, 2023
Casey Parker, Anne M. Hause, Paige Marquez, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Recommendations for Prevention and Control of Influenza in Children, 2024–2025: Technical Report
Sean T. O’Leary, James D. Campbell, Monica I. Ardura, et al.
PEDIATRICS (2024) Vol. 154, Iss. 4
Closed Access | Times Cited: 1
A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study)
J. Ramsay, Mark Jones, Ann Marie Vande More, et al.
Vaccine (2023) Vol. 41, Iss. 48, pp. 7250-7258
Open Access | Times Cited: 4
Role of Immunoglobulin A in COVID-19 and Influenza Infections
Rohit Tyagi, Srijani Basu, Atika Dhar, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1647-1647
Open Access | Times Cited: 3
Effectiveness of influenza vaccination against coronavirus disease (COVID)-19 outcomes in hospitalized individuals in Brazil: an epidemiological study
Nathália Mariana Santos Sansone, Matheus Negri Boschiero, Michelle Darrieux, et al.
Public Health (2023) Vol. 225, pp. 8-11
Closed Access | Times Cited: 2
Short-Term Adverse Effects of the Fourth Dose of Vaccination against COVID-19 in Adults over 40 Years of Age
Jussara Malo-Castillo, Harold Jiménez-Álvarez, Victor Ludeña-Meléndez, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 400-400
Open Access
Page 1 - Next Page

Scroll to top